NCT07255950

Brief Summary

  • The objective of this research is to determine the accuracy of different types of lung transthoracal needle aspiration (TTNA) i.e. jabbing-then-suction, suction-with-jabbing, and suction-only TTNA in patients with suspected lung cancer.
  • Researchers will compare these techniques to determine whether there are any quality differences in the obtained tumor samples

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

July 29, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

5 months

First QC Date

July 29, 2025

Last Update Submit

November 27, 2025

Conditions

Keywords

NSCLCNon-small cell lung cancerTransthoracal needle aspirationBiopsyDiagnostics

Outcome Measures

Primary Outcomes (1)

  • Quality of samples from different types of transthoracal needle aspiration (TTNA) technique

    To determine the quality of samples between the jabbing-then-suction technique, the suction-with-jabbing technique, and the suction-only technique of transthoracic needle aspiration procedures in patients with unsuspected lung cancer. The sample quality assessed includes the adequacy of the number of tumor cells for molecular examination and the concordance between cytology sample of each type of TTNA technique.

    Immediate after biopsy procedure

Study Arms (1)

Jabbing-then-Suction, Suction-with-Jabbing, and Suction-only Transthoracal Needle Aspiration (TTNA)

EXPERIMENTAL
Diagnostic Test: Jabbing-then-Suction, Suction-with-Jabbing, and Suction-only Transthoracal Needle Aspiration (TTNA) Techniques

Interventions

Each of patient will undergo three types of different transthoracal needle aspiration (TTNA)

Jabbing-then-Suction, Suction-with-Jabbing, and Suction-only Transthoracal Needle Aspiration (TTNA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with suspected lung cancer who will undergo diagnostic testing using ultrasound-guided TTNA of the lung with cell block and core biopsy.
  • Patients aged 18-75 years.
  • The tumor is located peripherally, attached to the chest wall.

You may not qualify if:

  • Patient refuses lung biopsy
  • Non-cooperative patient
  • Patient with respiratory failure, on positive pressure ventilation
  • Severe pulmonary emphysema
  • Contralateral pneumonectomy
  • Advanced pulmonary fibrosis
  • Platelet count \<100,000/mm3 and international normalized ratio (INR) \>1.4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitas Gadjah Mada Academic Hospital (RSA UGM)

Yogyakarta, Special Region of Yogyakarta, 55291, Indonesia

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsDiseaseCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCarcinoma, BronchogenicBronchial Neoplasms

Central Study Contacts

dr. Roihan Mohamad Iqbal

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The biopsy results, in a form of 20 cc syringe and slide containing the patient's tissue sample, will be labeled with a code by pulmonologist that will be blinded to the pathologist. The pathologist will then assess the adequacy of the cell count for molecular examination, evaluate the histopathological and cytopathological findings. Statisticians who will process the data are unaware of the allocation of each research item.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patient undergo the same intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2025

First Posted

December 1, 2025

Study Start

July 15, 2025

Primary Completion

December 1, 2025

Study Completion

February 1, 2026

Last Updated

December 1, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) collected during the trial reported in the article will be shared, after deidentification.

Shared Documents
STUDY PROTOCOL
Time Frame
IPD and supporting information will be available immediately following publication, without end date.
Access Criteria
Requestors who provide a methodologically sound proposal can access the our IPD data. Proposals should be directed to roihan.iqbal@gmail.com

Locations